Solute carrier family 7 member 11 cystine glutamate transporter (SLC7A11; xCT) BriefCommunication Pages: 1216 - 1216
Histone deacetylase 6 (HDAC6); microRNA-548m (miR-548m); c-Myc (MYC) BriefCommunication Pages: 1221 - 1221
Mycobacterium tuberculosis transmembrane transport protein 3 (mmpL3) BriefCommunication Pages: 1228 - 1228
Eukaryotic translation initiation factor 2α kinase 3 (EIF2AK3; PERK) BriefCommunication Pages: 1232 - 1232
Solute carrier family 12 potassium-chloride transporter member 5 (SLC12A5; KCC2) BriefCommunication Pages: 1233 - 1233
Metabolite suppression profiling to understand the mechanism of action for antibacterial compounds BriefCommunication Pages: 1236 - 1236
Bioinformatics-based approach to identify combined microRNA- and mRNA-derived cancer signatures BriefCommunication Pages: 1237 - 1237
In vitro model to predict pharmacokinetic parameters important to antimalarial drug efficacy BriefCommunication Pages: 1239 - 1239
Cyclodextrin-modified dendritic polyamine (DexAM) construct for delivery of stem cell differentiation factors BriefCommunication Pages: 1240 - 1240
Gene-specific transcriptional activation using DNA (cytosine-5-)-methyltransferase 1 (DNMT1)-RNA interactions BriefCommunication Pages: 1241 - 1241
Genomic rearrangements in the androgen receptor (AR) as an androgen-independent prostate cancer resistance mechanism BriefCommunication Pages: 1243 - 1243